Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    An update to the page revision from v3.6.2 to v3.6.3 was applied, signaling a new version of the page. This change records a version bump rather than a modification to the trial content.
    Difference
    0.1%
    Check dated 2026-07-07T02:40:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new Revision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This indicates a platform or content update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:44:59.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment status as No longer looking for participants. The Intervention/Treatment label is standardized (replacing Intervention / Treatment) and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:36:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision history now includes a new entry 'Revision: v3.5.5' and removes the previous 'Revision: v3.5.4' entry. This update represents a minor administrative change to the page metadata rather than user-facing content or functionality.
    Difference
    0.1%
    Check dated 2026-06-08T04:30:25.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    This page now shows Revision: v3.5.4, replacing the previous v3.5.3 revision. This indicates a small update to the page record without altering the study details or required actions for participants.
    Difference
    0.1%
    Check dated 2026-05-17T10:46:41.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page revision version from v3.5.2 to v3.5.3, reflecting a site/software metadata update rather than a change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:35:38.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.